cdr
Search

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
  1. Home
  2. About
  3. Junior Editorial Board

Junior Editorial Board

  • Pragati Agnihotri
    Advanced Bioscience Laboratories, Maryland, MD, USA.
    Research Interests: cancer immunotherapy, T-cell biology, drug discovery, LAG3, MHC.
  • Manoj P. Amrutkar
    Oslo University Hospital (Rikshospitalet), Department of Pathology, Oslo, Norway.
    Research Interests: chemoresistance, pancreatic cancer, tumor microenvironment, pharmacokinetics, metabolism, cell biology.
  • Reetobrata Basu
    Edison Biotechnology Institute, Ohio University, Athens, USA.
    Research Interests: growth hormone, cancer, receptors, drug efflux, EMT, combination therapy, immune-evasion, immune-therapy.
  • Bernhard Biersack
    Department of Chemistry, University of Bayreuth, Germany.
    Research Interests: medicinal chemistry, drug design, epigenetics, metal-based drugs, alkylating agents, tubulin-binding drugs, kinase inhibitors, HDAC inhibitors.
  • Minghui Cao
    Department of Pathology, University of California, San Diego, USA.
    Research Interests: extracellular vesicles, non-coding RNAs, metabolism, signaling transduction, breast cancer.
  • Ilana Chefetz
    Hormel Institute, University of Minnesota, Austin, MN, USA.
    Research Interests: ovarian cancer, cell death, necroptosis, cancer stem cells, chemoresistance, metabolism, DNA damage and repair, ovary and brain.
  • Hexin Chen
    Department of Biological Sciences, University of South Carolina, Columbia, USA.
    Research Interests: breast cancer biology, caner stem cells, microRNA, HER2-targeted therapy, immune escape mechanism, immunotherapy.
  • Ivy Chung
    Department of Pharmacology, Faculty of Medicine, University of Malaya, Malaysia.
    Research Interests: cancer therapeutics, tumor microenvironment, cancer-associated fibroblasts, drug pharmacology, drug resistance.
  • Mario Cioce
    Faculty of Medicine and Surgery, University Campus-Biomedico, Rome, Italy.
    Research Interests: mesothelioma, metformin, CSC, translational oncology, chemoresistance, TKI, Ephrin, EMT.
  • Viswanath Das
    Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University,Olomouc, Czech Republic.
    Research Interests: anti-cancer drug repurposing, hypoxia, small molecules, three-dimensional cell cultures.
  • Christophe Deben
    Universiteit Antwerpen, Antwerpen, Belgium.
    Research Interests: p53 pathway, non-small cell lung cancer, oxidative stress, PARP-1 inhibition, pancreatic cancer, targeted therapies.
  • Takanori Eguchi
    Okayama University, Okayama, Japan.
    Research Interests: exosomes, extracellular vesicles, 3D culture systems, tumoroids, protein moonlighting, cancer, omics, gene regulation.
  • Mohamed Elbadawy
    Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh, Elqaliobiya, Egypt.
    Research Interests: organoids, anticancer drugs, drug resistance, CSCs, bladder cancer, colorectal cancer.
  • Ana Rita Figueiras
    Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
    Research Interests: polymeric micelles, gene therapy, micelleplexes, controlled release.
  • Natalie R. Gassman
    University of South Alabama College of Medicine, University of South Alabama Mitchell Cancer Institute, Mobile, USA.
    Research Interests: triple negative breast cancer, DNA damage, DNA repair, base excision repair.
  • Shailendra Gautam
    University of Nebraska Medical Center, Omaha, NE, USA.
    Research Interests: cancer immunotherapy, targeted therapy, cancer metastasis, tumor microenvironment, animal models, pancreatic cancer, breast cancer metastasis.
  • Piyush Kumar Gupta
    Sharda University, Greater Noida, India.
    Research Interests: bio/nanomaterial, cancer drug delivery, phytonanomedicine and tissuee engineering.
  • Xin Hong
    Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
    Research Interests: circulating tumor cells (CTCs), liquid biopsy, cancer metastasis, non-invasive biomarkers.
  • Sachi Horibata
    Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, Michigan, USA.
    Research Interests: cancer drug resistance, cancer biology, genomics, precision oncology.
  • Haroon Khan
    Department of Pharmacy, Abdul Wali Khan University Mardan, 23200, Pakistan.
    Research Interests: drug discovery from natural product, cancer treatment, molecular mechanisms of anticancer agents, anticancer drug resistance.
  • Paweł Kowalczyk
    Department of Animal Nutrition, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Jabłonna, Poland.
    Research Interests: p53 gene, human cancers like liver and pancreas, oxidative stress in gastrointestinal tract, DNA repair, BER and NER pathway.
  • Arutha Kulasinghe
    Faculty of Medicine, The University of Queensland Diamantina Institute, Brisbane, Australia.
    Research Interests: spatial transcriptomics, lung cancer, head and neck cancer, liquid biopsy, COVID-19, biomarkers, immuno-oncology.
  • Ashish Kumar
    Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
    Research Interests: exosomes, miRNAs, prostate cancer, extracellular vesicles, stem cell.
  • Weiwen Long
    Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH, USA.
    Research Interests: growth factor signaling, steroid receptor/coactivator signaling, and the interplay between these two signaling pathways in cancer progression and metastasis.
  • Elena Mariotto
    University of Padova and Pediatric Research Institute, Padua, Italy.
    Research Interests: high throughput drug screening (HTS), medulloblastoma, acute lymphoblastic leukemia, pediatric cancer, cell cycle, apoptosis, kinase inhibitors.
  • Chiara Martinelli
    Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milan, Italy.
    Research Interests: cancer, theragnostics, targeted therapy, nanotechnology, nanomedicine, multifunctional nanomaterials, nanocarriers, drug delivery.
  • Zeyad Nassar
    The University of Adelaide, Adelaide, Australia.
    Research Interests: cancer biology, prostate cancer, lipid metabolism, angiogenesis and lymphangiogenesis, drug discovery.
  • Alessio Ottaviani
    Department of Biology, University of Rome "Tor Vergata", Rome, Italy.
    Research Interests: topoisomerase, cancer, drug development, DNA nanocage, drug delivery, CAR-T, immunotherapy.
  • Uday Pratap
    Department of Obstetrics and Gynecology, University of Texas Health San Antonio, San Antonio, TX, USA.
    Research Interests: Gynecological Cancer, Drug discovery, Neuroimmunology, Neuroendocrinology, Glioma, Targeted therapy, Immunology.
  • Yanrong Qian
    Edison Biotechnology Institute, Konneker Research Labs, Ohio University, Athens, OH, USA.
    Research Interests: cancer metabolism, the Warburg effect, energy homeostasis, growth hormone, drug resistance.
  • Monish Ram Makena
    Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
    Research Interests: preclinical drug testing, cell death assays, cell signaling pathways, drug resistance mechanisms.
  • Faisal Raza
    Shanghai Jiao Tong University, Shanghai, China.
    Research Interests: Cancer, targeted drug delivery, tumor microenvironment, cancer nanomedicine, biomimetic nanotechnology, biomaterials, Drug resistance.
  • Giandomenico Roviello
    Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
    Research Interests: immunotherapy, prostate cancer, gastric cancer, renal cell carcinoma, chemotherapy.
  • Sean Rudd
    Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
    Research Interests: genome stability, DNA replication, DNA repair, nucleotide metabolism, cancer therapy, precision medicine, drug resistance, drug combinations.
  • Vicenç Ruiz de Porras
    Catalan Institute of Oncology- Badalona Applied Research Group in Oncology (B·ARGO), Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain.
    Research Interests: metastatic prostate cancer, bladder cancer, therapy resistance, chemotherapy, target therapies, predictive biomarkers.
  • Vaishnavi Sambandam
    Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
    Research Interests: cancer biology, signaling pathways, biomarkers, apoptosis, PI3K/mTOR signaling, head and neck cancer, targeted therapy, ovarian cancer, stem cells.
  • Yohei Sekino
    Department of Molecular Pathology, Hiroshima University，Hiroshima, Japan.
    Research Interests: prostate cancer, renal cell carcinoma, bladder cancer, immunohistochemistry, drug resistance, molecular biology.
  • Zhi Shi
    Department of Cell Biology & Institute of Biomedicine, College of Life Science and Technology, Jinan University, China
    Research Interests: cancer drug resistance, anticancer drugs, cancer biomarker, cancer cell biology, protein-protein interaction, protein modification.
  • Samriddhi Shukla
    Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
    Research Interests: lung cancer, epigenetics, small molecule therapeutics, immunooncology, radiation biology.
  • Lubna H. Tahtamouni
    Department of Biochemistry and Molecular Biology, College of Natural Sciences, Colorado State University, Fort Collins, CO, USA.
    Research Interests: cell migration, actin cytoskeleton, ADF/cofilin, breast cancer, triple negative breast cancer, androgen receptor, targeted therapy.
  • Danh Truong
    University of Texas MD Anderson Cancer Center, Houston, United States.
    Research Interests: Cancer, sarcoma, plasticity, single-cell, bioinformatics, tumor microenvironment.
  • Milica Vucetic
    International society of cancer metabolism, European Society for Free Radical Research, Department of Medical Biology, Centre Scientifique de Monaco, Monaco.
    Research Interests: ferroptosis, amino acid transporters, cancer, redox regulation, oxidative stress, metabolism.
  • Mark Thomas Shaw Williams
    Department of Biological and Biomedical Sciences, Glasgow Caledonian University, Scotland, United Kingdom.
    Research Interests: acute lymphoblastic leukaemia, multiple myeloma, acute myeloid leukaemia, chemotherapy resistance.
  • ChunHua Yang
    Digestive Disease Research Group, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
    Research Interests: colon cancer therapeutics, biomimetic nano delivery systems, targeted drug delivery, digestive disease.
  • Yanlin Yu
    Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Research Interests: tumor metastasis, mouse models, tumor immunology, drug discovery, drug resistance, targeted therapy.
  • Giorgia Zadra
    Harvard Medical School, Boston, MA, USA.
    Research Interests: prostate cancer, cancer metabolism, metabolic imaging, metabolomics, diet&lipid metabolism, cancer microenvironment, resistance to endocrine therapies, cancer progression.
  • Xiangxuan Zhao
    Shengjing Hospital of China Medical University, Shenyang, China.
    Research Interests: natural products, cancer resistance, cancer biology, apoptosis, immunotherapy, exosomes, epigenetics.
close
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties